Analysis
Cutting-edge analyses, interviews, scoops and more in this edition.
1
Biopharma firm AusperBio secures $120m Series C to advance chronic hepatitis B therapies
2
EV maker Omega Seiki raises $5.2m funding, and other India deals
3
Temasek defends SIA's Air India investment amid growing scrutiny
4
Editor's Take: The Week That Was—August 24-29
5
Danantara’s $18.6b profit claim puts disclosure in focus
More Stories
Editor’s Take: The Week That Was—August 24-29
Asia’s IPO revival opens new exit routes for LPs
Aura Group launches private equity, credit evergreen fund
KKR, IMM to invest $2.1b in SK Telecom’s AI data centre platform
These questions come when Danantara’s structure has expanded rapidly this year.
Earnings and Results
Electrum’s stronger performance came as TBS’s portfolio continued to move towards non-coal businesses.
Deals
It plans to collaborate with Ajaib to promote circulation of JPYSC.
The stake increase involved two transactions worth a combined $4.9m.
CVC acquired a significant minority stake in Samator for about $155m in March 2023.
The partnership will connect Japanese investors with growth companies in SE Asia.
People
She could become the first woman to take the top job.
Total investment in the projects is estimated at $7.62b.
News Corp and REA Group have injected $9.2m into REA India.
